As used in this chapter, "interoperability" refers to the INSPECT program electronically sharing reported information with another state concerning the dispensing of a controlled substance:

1. (1) to a recipient who resides in the other state; or
2. (2) prescribed by a practitioner whose principal place of business is located in another state.

As added by P.L.51-2019, SEC.8.